With the rising global rates of cesarean sections, identifying safe and effective spinal anesthesia strategies has become increasingly important. This study, conducted at the Republican Perinatal Center of Uzbekistan, aimed to compare the hemodynamic and analgesic profiles of two intrathecal adjuvants—morphine and dexmedetomidine —in pregnant women with severe preeclampsia. Sixty patients were divided into two groups. The study evaluated anesthesia quality, postoperative pain management, side effects, and neonatal outcomes. Findings indicated that dexmedetomidine provided comparable analgesic efficacy to morphine with significantly fewer side effects, supporting its potential as a favorable adjuvant for spinal anesthesia in obstetric practice. In the Republican Perinatal Center of Uzbekistan, a scientific work was conducted to determine the optimal adjuvant for cesarean section in pregnant women with obstetric pathology - severe preeclampsia . A study was conducted on the quality of spinal anesthesia among pregnant women with severe preeclampsia using 2 types of adjuvants: morphine and dexmedetomidine.